RecruitingNot ApplicableNCT05757505

The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

The Efficacy and Safety of the Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective, Multicenter, Randomized Controlled, Non-inferiority Trial

Sponsor

Ton-Bridge Medical Tech. Co., Ltd

Enrollment

200 participants

Start Date

May 11, 2023

Study Type

INTERVENTIONAL

Conditions

Intracranial Atherosclerosis

Summary

The purpose of this study is to verify the efficacy and safety of the Intracranial Stent (Tonbridge) in endovascular treatment of symptomatic intracranial atherosclerotic stenosis.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Intracranial Stent (Tonbridge) and a medical device called Wingspan Stent System (Stryker Neurovascular) for people with intracranial atherosclerosis. The study is currently recruiting participants at 13 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEIntracranial Stent (Tonbridge)

Endovascular treatment with Intracranial Stent (Tonbridge).

DEVICEWingspan Stent System (Stryker Neurovascular)

Endovascular treatment with Wingspan Stent System (Stryker Neurovascular).

Locations(13)

The First Affiliated Hospital of Henan Science ＆ Technology University

Luoyang, Henan, China

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, China

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China

Jiangxi Provincial People's Hospital

Nanchang, Jiangxi, China

The First Hospital of Jilin University

Changchun, Jilin, China

The First Affiliated Hospital of Dalian Medical University

Dalian, Liaoning, China

Baotou City Central Hospital

Baotou, Neimenggu, China

First Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, China

Hangzhou First People's Hospital

Hangzhou, Zhejiang, China

Ningbo First Hospital

Ningbo, Zhejiang, China

Changhai Hospital of Shanghai

Shanghai, China

Shanghai Fourth People's Hospital

Shanghai, China

Tongji Hospitai of Tongji University

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05757505

Related Trials

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

NCT0690274019 locations

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

NCT072820411 location

IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)

NCT064723361 location

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD

NCT067145262 locations

Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study

NCT063361741 location